Calcium restores a normal proliferation phenotype in human polycystic kidney disease epithelial cells.

Polycystic kidney disease (PKD) is a lethal disorder characterized by progressive expansion of renal cysts. Genetic mutations associated with PKD are thought to disrupt intracellular Ca2+ regulation, leading to abnormal proliferation of tubule epithelial cells. cAMP stimulates the B-Raf/MEK/extracellular signal-regulated kinase (B-Raf/MEK/ERK) pathway and accelerates the proliferation of cells that are cultured from PKD cysts. By contrast, cAMP inhibits the proliferation of cells from normal human kidneys (NHK) and M-1 mouse collecting duct cells. Previously, it was found that a sustained reduction of intracellular Ca2+ levels in NHK and M-1 cells that were treated with Ca2+ entry blockers allowed cAMP activation of the B-Raf/MEK/ERK pathway, switching the cells to a cAMP-growth stimulated phenotype. In this study, primary cultures of cyst epithelial cells from autosomal dominant (ADPKD) and recessive (ARPKD) PKD kidneys were used to determine whether controlled addition of Ca2+ could reverse the aberrant mitogenic response to cAMP. Steady-state intracellular Ca2+ levels were found to be 20 nM lower in cyst-derived ADPKD cells (57 +/- 2 nM) compared with NHK cells (77 +/- 2 nM). Treatment of ADPKD cells or ARPKD cells with either Bay K8644, a Ca2+ channel activator, or A23187, a Ca2+ ionophore, caused sustained increases in intracellular Ca2+ levels and completely reversed the mitogenic response to cAMP. Elevation of intracellular Ca2+ levels in ADPKD cells increased Akt activity and blocked cAMP-dependent B-Raf and ERK activation. Thus, increases in [Ca2+]i are able to restore the normal anti-mitogenic response to cAMP in cells that are derived from two genetically distinct forms of PKD.

[1]  K. R. Spring,et al.  Bending the MDCK Cell Primary Cilium Increases Intracellular Calcium , 2001, The Journal of Membrane Biology.

[2]  W. Guggino,et al.  cAMP regulates cell proliferation and cyst formation in autosomal polycystic kidney disease cells. , 2000, Journal of the American Society of Nephrology : JASN.

[3]  Jing Zhou,et al.  Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells , 2003, Nature Genetics.

[4]  R. Maser,et al.  Developmental expression of urine concentration-associated genes and their altered expression in murine infantile-type polycystic kidney disease. , 1999, Developmental genetics.

[5]  T. Barber,et al.  Negative regulation of the serine/threonine kinase B-Raf by Akt. , 2000, The Journal of biological chemistry.

[6]  R. Tsien,et al.  A new generation of Ca2+ indicators with greatly improved fluorescence properties. , 1985, The Journal of biological chemistry.

[7]  S. Reeders.  Multilocus polycystic disease , 1992, Nature Genetics.

[8]  V. Torres,et al.  Effectiveness of vasopressin V2 receptor antagonists OPC-31260 and OPC-41061 on polycystic kidney disease development in the PCK rat. , 2005, Journal of the American Society of Nephrology : JASN.

[9]  S. Somlo,et al.  Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease , 2004, Nature Medicine.

[10]  D. Wallace,et al.  Chloride and fluid secretion by cultured human polycystic kidney cells. , 1996, Kidney international.

[11]  M. Sutters,et al.  Expression of polycystin-1 enhances endoplasmic reticulum calcium uptake and decreases capacitative calcium entry in ATP-stimulated MDCK cells. , 2005, American journal of physiology. Renal physiology.

[12]  G. Germino,et al.  Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents , 2000, Nature.

[13]  L P Sullivan,et al.  cAMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway. , 2000, Kidney international.

[14]  S. Somlo,et al.  Deficiency of polycystin‐2 reduces Ca2+ channel activity and cell proliferation in ADPKD lymphoblastoid cells , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  Patricia A. Gabow,et al.  PKD2, a Gene for Polycystic Kidney Disease That Encodes an Integral Membrane Protein , 1996, Science.

[16]  S. Puri,et al.  Polycystin-1 Activates the Calcineurin/NFAT (Nuclear Factor of Activated T-cells) Signaling Pathway* , 2004, Journal of Biological Chemistry.

[17]  D. Wallace,et al.  Chloride and fluid secretion in polycystic kidney disease. , 1998, Journal of the American Society of Nephrology : JASN.

[18]  Vincent H Gattone,et al.  Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist , 2003, Nature Medicine.

[19]  P. Harris.  Molecular basis of polycystic kidney disease: PKD1, PKD2 and PKHD1 , 2002, Current opinion in nephrology and hypertension.

[20]  D. Wallace,et al.  Cyclic AMP promotes growth and secretion in human polycystic kidney epithelial cells. , 2004, Kidney international.

[21]  O. Ibraghimov-Beskrovnaya,et al.  Cation channel regulation by COOH-terminal cytoplasmic tail of polycystin-1: mutational and functional analysis. , 2002, Physiological genomics.

[22]  P. S. St George-Hyslop,et al.  Somatic PKD2 mutations in individual kidney and liver cysts support a "two-hit" model of cystogenesis in type 2 autosomal dominant polycystic kidney disease. , 1999, Journal of the American Society of Nephrology : JASN.

[23]  J. Grantham.  1992 Homer Smith Award. Fluid secretion, cellular proliferation, and the pathogenesis of renal epithelial cysts. , 1993, Journal of the American Society of Nephrology : JASN.

[24]  D. Beier,et al.  Germline and somatic loss of function of the mouse cpk gene causes biliary ductal pathology that is genetically modulated. , 2000, Human molecular genetics.

[25]  S. Somlo,et al.  Polycystin-2 is an intracellular calcium release channel , 2002, Nature Cell Biology.

[26]  James P Calvet,et al.  Calcium Restriction Allows cAMP Activation of the B-Raf/ERK Pathway, Switching Cells to a cAMP-dependent Growth-stimulated Phenotype* , 2004, Journal of Biological Chemistry.

[27]  J. Grantham,et al.  In vitro formation and expansion of cysts derived from human renal cortex epithelial cells. , 1992, Kidney international.

[28]  E. Henske,et al.  Loss of the polycystic kidney disease (PKD1) region of chromosome 16p13 in renal cyst cells supports a loss-of-function model for cyst pathogenesis. , 1997, The Journal of clinical investigation.

[29]  S. Somlo,et al.  Pkd2 haploinsufficiency alters intracellular calcium regulation in vascular smooth muscle cells. , 2003, Human molecular genetics.

[30]  Vicente E. Torres,et al.  The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein , 2002, Nature Genetics.

[31]  G. Germino,et al.  Molecular basis of autosomal dominant polycystic kidney disease. , 1999, Seminars in nephrology.

[32]  N. LaRusso,et al.  Cellular and subcellular localization of the ARPKD protein; fibrocystin is expressed on primary cilia. , 2003, Human molecular genetics.

[33]  J. Pelling,et al.  Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys. , 2003, Kidney international.

[34]  F. Qian,et al.  Somatic mutation as mechanism for cyst formation in autosomal dominant polycystic kidney disease. , 1999, Molecular genetics and metabolism.

[35]  A. Bakkaloğlu,et al.  Mutation analysis of the entire PKD1 gene: genetic and diagnostic implications. , 2001, American journal of human genetics.

[36]  Martijn H Breuning,et al.  Lowering of Pkd1 expression is sufficient to cause polycystic kidney disease. , 2004, Human molecular genetics.